In vivo model developed for evaluating the cytokine release toxicity of bispecific antibodies May 21, 2021 No Comments
Basket evaluation of atezolizumab with BDB-001 and radiotherapy in multiple solid tumors May 21, 2021 No Comments
Phase I/II study evaluates CD19 and BCMA CAR T cells in patients with acute leukemia May 21, 2021 No Comments
GammaDelta cleared to conduct phase I study of Vdelta1 gamma-delta T-cell therapy GDX-012 May 20, 2021 No Comments
Crescendo Biologics begins phase I study of CB-307 in advanced PSMA-positive solid tumors May 20, 2021 No Comments
China's NMPA approves initiation of phase I/II trial of AK-117 for medium- to high-risk MDS May 20, 2021 No Comments
Hanmi initiates phase II study of FLX-475 in combination with pembrolizumab in gastric cancer May 20, 2021 No Comments
Enrollment begins in investigator-initiated study of D2C7-IT plus 2141-V11 in recurrent glioma May 19, 2021 No Comments
ImmunityBio receives FDA authorization for phase I study of its m-ceNK platform May 19, 2021 No Comments